Supplementation with magnesium and vitamin E were more effective than magnesium alone to decrease plasma lipids and blood viscosity in diabetic rats

Nutrition Research

Volumn 29, Issue 7, 2009, Pages 519-524

  Dou, Mei ^a,b   Ma, Ai Guo ^b   Wang, Qiu Zhen ^b   Liang, Hui ^b   Li, Yong ^b   Yi, Xue Mei ^b   Zhang, Shi Cui ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Blood viscosity; Diabetes; Magnesium; Rat; Total cholesterol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MAGNESIUM; MALONALDEHYDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VISCOSITY; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR RATE; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WISTAR RAT;

ANIMALS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; BLOOD VISCOSITY; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIET; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; LIPIDS; MAGNESIUM; MALE; MALONDIALDEHYDE; RATS; RATS, WISTAR; VITAMIN E;

RATTUS;

EID: 68849114753     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.07.001     Document Type: Article

References (33)

1. Savage D.B., Petersen K.F., and Shulman G.I. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87 (2007) 507-520
2. Høieggen A., Fossum E., Moan A., Enger E., and Kjeldsen S.E. Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens 16 (1998) 203-210
3. Caimi G., Sinagra D., Scarpitta A.M., and Lo R. Presti Plasma viscosity and insulin resistance in metabolic syndrome. Int J Obes Relat Metab Disord 25 (2001) 1856-1857
4. Tamariz L.J., Young J.H., Pankow J.S., Yeh H.C., Schmidt M.I., Astor B., et al. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 168 (2008) 1153-1160
5. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 49 Suppl (2000) 27-29
6. Salonen J.T., Nyyssonen K., Tuomainen T.P., Mäenpää P.H., Korpela H., Kaplan G.A., et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow-up study in men. Br J Med 311 (1995) 1124-1127
7. Ihara Y., Yamada Y., Toyokuni S., Miyawaki K., Ban N., Adachi T., et al. Antioxidant alpha-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett 473 (2000) 24-26
8. Laight D.W., Desai K.M., Gopaul N.K., Anggård E.E., and Carrier M.J. F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur J Pharmacol 377 (1999) 89-92
9. Laight D.W., Desai K.M., Gopaul N.K., Anggård E.E., and Carrier M.J. Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat. Br J Pharmacol 128 (1999) 269-271
10. Paolisso G., D'Amore A., Galzerano D., Balbi V., Giugliano D., Varricchio M., et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 16 (1993) 1433-1437
11. Tabatabaei S.R., Papahn A.A., Jalali M.R., and Rahimi L. The effects of oral vitamin E on induction and consequence of experimental diabetes mellitus in rats. Pak J Biol Sci 11 (2008) 633-637
12. Cinar M.G., Ulker S., Alper G., and Evinç A. Effect of dietary vitamin E supplementation on vascular reactivity of thoracic aorta in streptozotocin-diabetic rats. Pharmacology 62 (2001) 56-64
13. Chung T.W., Yu J.J., and Liu D.Z. Reducing lipid peroxidation stress of erythrocyte membrane by alpha-tocopherol nicotinate plays an important role in improving blood rheological properties in type 2 diabetic patients with retinopathy. Diabet Med 15 (1998) 380-385
14. Saris N.E., Mervaala E., Karppanen H., Khawaja J.A., and Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 294 (2000) 1-26
15. Barbagallo M., Dominguez L.J., Galioto A., Ferlisi A., Cani C., Malfa L., et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 24 (2003) 39-52
16. Jr J.R., and White R.K. Campbell, magnesium and diabetes. Ann Pharmacother 27 (1993) 775-780
17. Mather H.M., Nisbet J.A., Burton G.H., Poston G.J., Bland J.M., Bailey P.A., et al. Hypomagnesaemia in diabetes. Clin Chim Acta 95 (1979) 235-242
18. Sjogren A., Floren C.H., and Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 224 (1988) 461-466
19. Huerta M.G., Roemmich J.N., Kington M.L., Bovbjerg V.E., Weltman A.L., Holmes V.F., et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 28 (2005) 1175-1181
20. de Valk H.W. Magnesium in diabetes mellitus. Neth J Med 54 (1999) 139-146
21. Paolisso G., Scheen A., D'Onofrio F., and Lefèbvre P. Magnesium and glucose homeostasis. Diabetologia 33 (1990) 511-514
22. Resnick L.M. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of syndrome X. Am J Hypertens 6 (1993) 123S-134S
23. Rodriguez-Moran M., and Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. A randomized, double-blind controlled trial. Diabetes Care 26 (2003) 1147-1152
24. Paolisso G., Sgambato S., Gambardella A., Pizza G., Tesauro P., Varricchio M., et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 55 (1992) 1161-1167
25. Corica F., Allegra A., Di Benedetto A., Giacobbe M.S., Romano G., Cucinotta D., et al. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 7 (1994) 43-47
26. Wasowicz W., Neve J., and Perets A. Optimized steps in flourometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chim 39 (1993) 2522-2526
27. Gao Y., Yu W.G., Han F., Lu X.Z., Gong Q.H., Hu X.K., et al. Effect of propylene glycol mannate sulfate on blood lipids and lipoprotein lipase in hyperlipidemic rat. Yao Xue Xue Bao 37 (2002) 687-690
28. Liu D.Z., Chien S.C., Tseng L.P., and Yang C.B. The influence of hyperbaric oxygen on hemorheological parameters in diabetic rats. Biorheology 40 (2003) 605-612
29. Huang L., Guo J., Yang Z., and Gao Q.H. Effect of bilirubin and vitamin E on antioxidant in pancreas tissues of diabetic rats. China Public Health 20 (2004) 164-165
30. Hao M., Head W.S., Gunawardana S.C., Hasty A.H., and Piston D.W. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 56 (2007) 2328-2338
31. He K., Liu K., Daviglus M.L., Morris S.J., Loria C.M., Van Horn L., et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113 (2006) 1675-1682
32. Singh U., Otvos J., Dasgupta A., de Lemos J.A., Devaraj S., and Jialal I. High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy. Clin Chem 53 (2007) 525-528
33. Manuely Keenoy B., Shen H., Engelen W., Vertommen J., Van Dessel G., Lagrou A., et al. Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitus. J Nutr 131 (2001) 1723-1730